Ocugen Inc (OCGN)

Dec 10, 2025

Ocugen CEO to Present at Oppenheimer Movers in Rare Disease Summit - Ocugen

Dec 10, 2025

Dec 10, 2025

Ocugen, Inc. Chairman and CEO Dr. Shankar Musunuri to Present at Oppenheimer Movers in Rare Disease Summit - Quiver Quantitative

Dec 10, 2025

Dec 09, 2025

Major Fund Manager Acquires Significant Stake in Ocugen Amid Share Price Weakness - AD HOC NEWS

Dec 09, 2025

Dec 08, 2025

Ocugen Inc. Stock Falls Friday, Underperforms Market - 富途牛牛

Dec 08, 2025

Dec 08, 2025

Institutional Backing and Geopolitical Tailwinds for Ocugen - AD HOC NEWS

Dec 08, 2025

Dec 08, 2025

Ocugen Secures Validating Partnership for Gene Therapy Platform - Ad-hoc-news.de

Dec 08, 2025

Dec 05, 2025

How robust is Ocugen Inc. (2H51) stock financial positionMarket Volume Summary & Long Hold Capital Preservation Tips - Newser

Dec 05, 2025

Dec 05, 2025

Why institutional investors increase stakes in Ocugen Inc. (2H51) stockJuly 2025 Macro Moves & Reliable Volume Spike Trade Alerts - Newser

Dec 05, 2025

Dec 05, 2025

How Ocugen Inc. (2H51) stock compares with tech leadersEarnings Growth Summary & Weekly Hot Stock Watchlists - Newser

Dec 05, 2025

Dec 04, 2025

Is Ocugen Inc. (2H51) stock resilient in recession scenarios2025 Stock Rankings & Weekly Watchlist of Top Performers - Newser

Dec 04, 2025

Dec 04, 2025

Why Ocugen Inc. stock appeals to analystsWeekly Trade Analysis & Risk Controlled Swing Alerts - Newser

Dec 04, 2025

Dec 04, 2025

Ocugen CEO to Spotlight Gene Therapy Breakthroughs at High-Profile Growth Conference - MSN

Dec 04, 2025

Dec 03, 2025

Ocugen Inc. stock rises Wednesday, outperforms market - MarketWatch

Dec 03, 2025

Dec 03, 2025

Can Ocugen Inc. (2H51) stock deliver consistent EPS growth2025 Volatility Report & Safe Capital Growth Stock Tips - Newser

Dec 03, 2025

Dec 02, 2025

Is Ocugen Inc. (2H51) stock good for long term investingRisk Management & Free Community Consensus Stock Picks - Newser

Dec 02, 2025

Nov 29, 2025

How the Narrative Surrounding Ocugen Is Shifting After New Licensing and Analyst Developments - Yahoo Finance

Nov 29, 2025

Nov 28, 2025

Ocugen Inc. stock rises Friday, outperforms market - MarketWatch

Nov 28, 2025

Nov 27, 2025

Ocugen to Announce Third-Quarter 2025 Results and Business Update on November 5 - MSN

Nov 27, 2025

Nov 27, 2025

Ocugen Receives FDA Greenlight for Phase 1 Trial of Mucosal COVID-19 Vaccine - MSN

Nov 27, 2025

Nov 26, 2025

Ocugen Inc 2H51 Stock Analysis and ForecastEarnings Surprise Analysis & Low Cost Capital Trading - earlytimes.in

Nov 26, 2025

Nov 25, 2025

Ocugen, Inc.Common Stock (NQ: OCGN - Markets Financial Content

Nov 25, 2025

Nov 25, 2025

Ocugen Inc. stock falls Tuesday, underperforms market - MarketWatch

Nov 25, 2025

Nov 24, 2025

Ocugen Inc. stock rises Monday, outperforms market - MarketWatch

Nov 24, 2025

Nov 24, 2025

OCGN Stock Price and Chart — NASDAQ:OCGN - TradingView

Nov 24, 2025

Nov 21, 2025

Ocugen, Inc. (OCGN) Stock Price | Live Quotes & Charts | NASDAQ - StocksToTrade

Nov 21, 2025

Nov 21, 2025

Will Ocugen Inc. (2H51) stock outperform energy sector in 20252025 EndofYear Setup & Verified Trade Idea Suggestions - newser.com

Nov 21, 2025

Nov 21, 2025

Is Ocugen Inc. stock a defensive play in 20252025 Dividend Review & Real-Time Market Trend Scan - newser.com

Nov 21, 2025

Nov 21, 2025

Why retail investors favor Ocugen Inc. stockWeekly Trend Summary & AI Forecasted Stock Moves - newser.com

Nov 21, 2025

Nov 20, 2025

Ocugen CEO to Present at NobleCon21—Noble Capital Markets’ Twenty-First Annual Emerging Growth Equity Conference - Ocugen

Nov 20, 2025

Nov 20, 2025

How Ocugen Inc. (2H51) stock trades after rate cuts2025 Price Action Summary & Verified Technical Signals - newser.com

Nov 20, 2025

Nov 20, 2025

Ocugen CEO to Present at NobleCon21-Noble Capital Markets’ Twenty-First Annual Emerging Growth Equity Conference - The Manila Times

Nov 20, 2025

Nov 20, 2025

Ocugen CEO Dr. Shankar Musunuri to Present at NobleCon21 Conference on Advancements in Gene Therapies for Blindness Diseases - Quiver Quantitative

Nov 20, 2025

Nov 20, 2025

Ocugen CEO to Present at NobleCon21—Noble Capital Markets’ Twenty-First Annual Emerging Growth ... - Herald and News

Nov 20, 2025

Nov 20, 2025

Ocugen CEO to Present at NobleCon21—Noble Capital Markets’ - GlobeNewswire

Nov 20, 2025

Nov 20, 2025

Why Ocugen Inc. (2H51) stock could outperform next yearPortfolio Value Summary & AI Optimized Trading Strategy Guides - newser.com

Nov 20, 2025

Nov 20, 2025

Is Ocugen Inc. showing signs of accumulationSwing Trade & Weekly Top Performers Watchlists - newser.com

Nov 20, 2025

Nov 20, 2025

How Ocugen Inc. stock reacts to job market data2025 Momentum Check & Low Drawdown Trading Strategies - newser.com

Nov 20, 2025

Nov 20, 2025

Can Ocugen Inc. stock continue upward trendJuly 2025 Selloffs & Real-Time Volume Analysis - newser.com

Nov 20, 2025

Nov 19, 2025

Analyzing net buyer seller activity in Ocugen Inc.2025 Trading Recap & Real-Time Chart Pattern Alerts - newser.com

Nov 19, 2025

Nov 19, 2025

What hedge fund moves indicate for Ocugen Inc. (2H51) stockRisk Management & Consistent Profit Alerts - newser.com

Nov 19, 2025